Michelle Lai

603 total citations
17 papers, 415 citations indexed

About

Michelle Lai is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michelle Lai has authored 17 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Hepatology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michelle Lai's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (6 papers) and Diet, Metabolism, and Disease (6 papers). Michelle Lai is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (6 papers) and Diet, Metabolism, and Disease (6 papers). Michelle Lai collaborates with scholars based in United States, Israel and Switzerland. Michelle Lai's co-authors include Elliot B. Tapper, Murray A. Mittleman, Daniel Finkelstein, Gail Piatkowski, Nezam H. Afdhal, Gary L. Horowitz, Neil Sengupta, Daryl Lau, Rosemary Kane and Tracy Challies and has published in prestigious journals such as Annals of Internal Medicine, Hepatology and The American Journal of Medicine.

In The Last Decade

Michelle Lai

16 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Lai United States 11 240 211 102 85 64 17 415
Takao Miwa Japan 11 214 0.9× 194 0.9× 139 1.4× 81 1.0× 34 0.5× 71 395
Preya Patel Australia 15 458 1.9× 351 1.7× 34 0.3× 98 1.2× 118 1.8× 41 669
Juliette Tavenier Denmark 12 100 0.4× 52 0.2× 114 1.1× 52 0.6× 9 0.1× 29 370
Julie Steen Pedersen Denmark 13 232 1.0× 169 0.8× 67 0.7× 160 1.9× 83 1.3× 28 538
Amanda Cheung United States 9 435 1.8× 209 1.0× 81 0.8× 92 1.1× 179 2.8× 29 557
Beverley Kok Canada 9 136 0.6× 158 0.7× 34 0.3× 52 0.6× 13 0.2× 13 226
Sarah Wernly Austria 10 176 0.7× 57 0.3× 27 0.3× 72 0.8× 92 1.4× 31 286
Jungkuk Lee South Korea 10 98 0.4× 28 0.1× 24 0.2× 85 1.0× 75 1.2× 52 361
Prateek Lohia United States 9 100 0.4× 27 0.1× 39 0.4× 49 0.6× 52 0.8× 26 311
Amnart Chaiprasert Thailand 11 105 0.4× 40 0.2× 40 0.4× 58 0.7× 62 1.0× 25 421

Countries citing papers authored by Michelle Lai

Since Specialization
Citations

This map shows the geographic impact of Michelle Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Lai more than expected).

Fields of papers citing papers by Michelle Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Lai. The network helps show where Michelle Lai may publish in the future.

Co-authorship network of co-authors of Michelle Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Lai. A scholar is included among the top collaborators of Michelle Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Lai. Michelle Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lai, Michelle, et al.. (2025). Metabolic Dysfunction–Associated Steatotic Liver Disease. Annals of Internal Medicine. 178(1). ITC1–ITC16. 9 indexed citations
2.
Amjad, Waseem, Z. Gordon Jiang, & Michelle Lai. (2024). Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosis. European Journal of Gastroenterology & Hepatology. 36(8). 1038–1045.
3.
Trivedi, Hirsh D., et al.. (2023). Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c. Annals of Hepatology. 28(3). 101087–101087. 5 indexed citations
4.
Gonzalez, Adriano Miziara, et al.. (2021). Six-minute walking test performance is associated with survival in cirrhotic patients. World Journal of Hepatology. 13(11). 1791–1801. 6 indexed citations
5.
Lai, Michelle, et al.. (2020). Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting. Hepatology Communications. 5(2). 158–167. 48 indexed citations
6.
Yang, Wanshui, Jing Sui, Yanan Ma, et al.. (2020). High Dietary Intake of Vegetable or Polyunsaturated Fats Is Associated With Reduced Risk of Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology. 18(12). 2775–2783.e11. 37 indexed citations
7.
Ezaz, Ghideon, Hirsh D. Trivedi, Margery A. Connelly, et al.. (2020). Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD. Hepatology Communications. 4(5). 670–680. 29 indexed citations
8.
Danford, Christopher J., Margery A. Connelly, Irina Shalaurova, et al.. (2018). A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease. Hepatology Communications. 2(12). 1467–1478. 10 indexed citations
9.
Jiang, Z. Gordon, Elliot B. Tapper, Mi-Sung Kim, et al.. (2017). Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology. 52(5). 444–451. 11 indexed citations
10.
Tapper, Elliot B., Neil Sengupta, Michelle Lai, & Gary L. Horowitz. (2015). Understanding and Reducing Ceruloplasmin Overuse with a Decision Support Intervention for Liver Disease Evaluation. The American Journal of Medicine. 129(1). 115.e17–115.e22. 20 indexed citations
11.
Tapper, Elliot B., Daniel Finkelstein, Murray A. Mittleman, Gail Piatkowski, & Michelle Lai. (2015). Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 62(2). 584–590. 150 indexed citations
12.
Tapper, Elliot B., Neil Sengupta, Michelle Lai, & Gary L. Horowitz. (2015). A Decision Support Tool to Reduce Overtesting for Ceruloplasmin and Improve Adherence With Clinical Guidelines. JAMA Internal Medicine. 175(9). 1561–1561. 10 indexed citations
13.
Tapper, Elliot B., Katherine M. Krajewski, Michelle Lai, et al.. (2014). Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease. Gastroenterology report. 2(4). 276–280. 44 indexed citations
14.
Tapper, Elliot B., et al.. (2013). The Overuse of Serum Ceruloplasmin Measurement. The American Journal of Medicine. 126(10). 926.e1–926.e5. 15 indexed citations
15.
Karp, Seth J., Scott R. Johnson, Amy Evenson, et al.. (2011). Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. HPB. 13(6). 411–416. 16 indexed citations
16.
Lai, Michelle. (2010). Do We Need to Change Our National Organ Donation Policy?. Hepatology. 51(5). 1479–1482. 4 indexed citations
17.
Malik, Rohan, Michelle Lai, K. Ramakrishnan Bhaskar, et al.. (2008). 948 IDENTIFICATION OF BIOMARKERS THAT MEASURE DISEASE ACTIVITY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. Journal of Hepatology. 48. S355–S355. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takao Miwa Breakdown of academic impact, for papers by Preya Patel Breakdown of academic impact, for papers by Juliette Tavenier Breakdown of academic impact, for papers by Julie Steen Pedersen Breakdown of academic impact, for papers by Amanda Cheung Breakdown of academic impact, for papers by Beverley Kok Breakdown of academic impact, for papers by Sarah Wernly Breakdown of academic impact, for papers by Jungkuk Lee Breakdown of academic impact, for papers by Prateek Lohia Breakdown of academic impact, for papers by Amnart Chaiprasert
Rankless by CCL
2026